Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
4.810
+0.390 (8.82%)
Aug 21, 2026, 12:22 PM EDT - Market open
Armata Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 23.95 | 8.69 | 9.29 | 13.52 | 14.85 | 10.29 |
Cash & Short-Term Investments | 23.95 | 8.69 | 9.29 | 13.52 | 14.85 | 10.29 |
Cash Growth | 453.42% | -6.49% | -31.30% | -8.95% | 44.36% | 6.62% |
Other Receivables | 2.53 | 0.47 | 0.74 | 3.36 | 8.53 | 2.99 |
Receivables | 2.53 | 0.47 | 0.74 | 3.36 | 8.53 | 2.99 |
Prepaid Expenses | 0.67 | 1.51 | 1.27 | 2.27 | 3.66 | 1.72 |
Total Current Assets | 27.16 | 10.67 | 11.31 | 19.15 | 27.05 | 15 |
Property, Plant & Equipment | 44.11 | 46.11 | 54.93 | 57.28 | 46.65 | 38.07 |
Goodwill | 3.49 | 3.49 | 3.49 | 3.49 | 3.49 | 3.49 |
Long-Term Deferred Charges | 10.26 | 10.26 | 10.26 | 10.26 | 10.26 | 10.26 |
Other Long-Term Assets | 4.93 | 6.36 | 6.46 | 8.19 | 8.39 | 2.96 |
Total Assets | 89.95 | 76.88 | 86.44 | 98.36 | 95.83 | 69.77 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.19 | 0.92 | 0.77 | 1.59 | 1.68 | 1.14 |
Accrued Expenses | 2.71 | 2.98 | 3.57 | 4.87 | 6.18 | 2.17 |
Current Portion of Long-Term Debt | 241.48 | - | 38.95 | - | - | - |
Current Portion of Leases | 4.62 | 4.56 | 4.43 | 9.48 | 17.01 | 1.51 |
Other Current Liabilities | 0.2 | 0.49 | 0.53 | 0.52 | - | - |
Total Current Liabilities | 250.2 | 8.95 | 48.25 | 16.46 | 24.87 | 4.81 |
Long-Term Debt | 42.02 | 256.92 | 55.44 | 82.31 | - | - |
Long-Term Leases | 25.82 | 26.53 | 27.69 | 28.58 | 31.8 | 36.48 |
Long-Term Deferred Tax Liabilities | 3.08 | 3.08 | 3.08 | 3.08 | 3.08 | 3.08 |
Total Liabilities | 321.12 | 295.48 | 134.46 | 130.43 | 59.75 | 44.37 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.37 | 0.36 | 0.36 | 0.36 | 0.36 | 0.27 |
Additional Paid-In Capital | 311.2 | 282.57 | 279.35 | 276.39 | 275.49 | 227.98 |
Retained Earnings | -542.74 | -501.53 | -327.74 | -308.82 | -239.77 | -202.86 |
Shareholders' Equity | -231.17 | -218.6 | -48.02 | -32.07 | 36.08 | 25.4 |
Total Liabilities & Equity | 89.95 | 76.88 | 86.44 | 98.36 | 95.83 | 69.77 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 313.95 | 288.02 | 126.52 | 120.37 | 48.82 | 37.99 |
Net Cash (Debt) | -290 | -279.33 | -117.22 | -106.85 | -33.96 | -27.7 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -7.95 | -7.71 | -1.98 | -2.96 | -0.99 | -1.15 |
Filing Date Shares Outstanding | 37.18 | 36.63 | 36.18 | 36.15 | 36.14 | 30.73 |
Total Common Shares Outstanding | 37.15 | 36.43 | 36.18 | 36.12 | 36.14 | 27.11 |
Working Capital | -223.04 | 1.72 | -36.94 | 2.69 | 2.17 | 10.18 |
Book Value Per Share | -6.22 | -6.00 | -1.33 | -0.89 | 1.00 | 0.94 |
Tangible Book Value | -234.66 | -222.09 | -51.51 | -35.56 | 32.59 | 21.91 |
Tangible Book Value Per Share | -6.32 | -6.10 | -1.42 | -0.98 | 0.90 | 0.81 |
Machinery | 19.02 | 22.43 | 22.59 | 12.83 | 11.27 | 9.02 |
Construction In Progress | 3.5 | - | - | 8.1 | - | - |
Leasehold Improvements | 3.81 | 3.8 | 3.8 | 3.45 | 3.45 | 3.42 |